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We performed a cross-border molecular epidemiology anal-
ysis of multidrug-resistant tuberculosis in Peru, Spain, and 
Italy. This analysis revealed frequent transmission in Peru 
and exportation of a strain that recreated similar levels of 
transmission in Europe during 2007–2017. Transnational 
efforts are needed to control transmission of multidrug- 
resistant tuberculosis globally.
International migratory movements have created a need for cross-border surveillance of tuberculosis (TB). Moni-
toring the transmission of multidrug-resistant (MDR) My-
cobacterium tuberculosis strains deserves further analysis 
(1). Through migration, MDR strains can become more 
widely dispersed; they can be exported from the 30 coun-
tries with 89.7% of the incident MDR cases (2) to lower 
prevalence settings.
We performed a transnational molecular epidemiology 
analysis of MDR TB cases covering a setting with one of 
the highest resistance rates in Latin America (Lima, Peru) 
(2) and 2 settings in Europe hosting immigrants from Peru 
(Florence, Italy; and Madrid, Spain) to identify incidents 
of cross-border transmission. We selected 60 consecutive 
MDR TB cases (20% of the total MDR cases in Lima) di-
agnosed during 2014–2015 in one of the poorest districts 
of Lima (San Juan de Lurigancho), which has the highest 
incidence of TB (193 cases/100,000 population) in Peru 
(3). MIRU-VNTR (mycobacterial interspersed repetitive 
unit–variable-number tandem-repeat) analysis (Appendix 
1, https://wwwnc.cdc.gov/EID/article/25/3/18-0574-App1.
pdf) suggested a high percentage of recent transmission that 
included 36 (60%) of 60 isolates in 9 clusters (Appendix 2, 
https://wwwnc.cdc.gov/EID/article/25/3/18-0574-App2.
xlsx). A comparison of these isolates with 228 genotyped 
isolates from the same district 4 years earlier (3) revealed 
that 6 of the 9 strains actively transmitted during 2014–
2015 were present in 2011 (Appendix 1 Table 1).
We then investigated whether some of these persis-
tent MDR TB strains actively transmitted in Lima could 
have been exported to Europe. We used a dataset of 87 
MIRU-VNTR genotypes of isolates in Florence obtained 
from TB cases in Peru during 2001–2010 (4) and >300 
MDR genotyped isolates obtained nationwide from Italy 
(5). We found that 1 genotype matched between the Lima 
and Italy MDR datasets; this genotype corresponded to a 
strain (C8-LPMDR) that infected 11 persons in Florence 
and 2 in Milan during 2007–2017 (Appendix 1 Table 2). 
MDR TB strains from Lima were also found in Spain dur-
ing 2003–2009. Three MDR isolates, matching 3 of the 9 
MDR TB strains from Lima, were found in migrants from 
Peru residing in Madrid (Appendix 1 Table 1). One of these 
isolates corresponded to the active MDR strain circulating 
in Italy (C8-LPMDR).
We performed whole-genome sequencing (6) with 12 
of the 17 isolates of the cross-border MDR TB cluster C8-
LPMDR (7 from Florence, 2 from Milan, 2 from Lima, 
and 1 from Madrid). In a median-joining network analy-
sis, these isolates were distributed along 2 branches (Fig-
ure). One branch included all the isolates from Florence. 
Although we lacked precise data from contact tracing 
to verify details regarding transmission in Florence, we 
were able to determine that all the Peru migrants involved 
came from Lima. In Florence, there is a large commu-
nity of persons from Peru, which offers opportunities for 
interacting, such as shared residence and social gather-
ings. The few differences (0–2 single-nucleotide polymor-
phisms [SNPs]) found among these isolates strongly sug-
gests these isolates were recently transmitted in Florence. 
An isolate from Lima (6068) was only 3 SNPs different 
from a Florence isolate, demonstrating a close genetic 
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relationship between the Florence and Lima isolates. This 
close relationship also suggests that the starting point of 
this branch was an exportation event of an isolate from 
Lima. The second branch in the network includes 2 iso-
lates identified in Europe (1 Madrid [city of origin un-
known, data not available] and 1 Milan [origin Lima]) and 
1 isolate identified in Lima. Because the most recent com-
mon ancestor is positioned between the 2 branches and 
the 2 isolates from Lima are in different branches, these 
branches probably represent 2 independent exportations 
of 2 variants of a strain prevalent in Lima that diversified 
after a prolonged period.
These data reveal that high-risk strains are being 
exported from Lima to 2 countries of Europe (Italy and 
Spain). Not only were these strains exported from Lima, 
but 1 strain caused a prolonged and ongoing transmission 
event in Italy. The transmission of this strain has caused 
at least 3 cases in Lima, 11 in Florence, 2 in Milan, and 
1 in Madrid.
In another report, the international distribution of an 
MDR TB strain that caused 10 cases across 3 countries of 
Europe (Romania, Austria, and Germany) was investigated 
(7). The exportation event discussed in our report is geo-
graphically wider (intercontinental, from South America to 
Europe), involved more cases (17 total, with a transmission 
cluster of 12 cases in Italy), and occurred over a more ex-
tended period (secondary cases spanned 11 years).
Only integrative transnational efforts can provide a 
clearer picture of transmission of MDR TB, which has be-
come more complex because of international migration. In 
this cooperative analysis involving Peru, Italy, and Spain, we 
detected a serious problem of active MDR TB transmission 
in Lima. This situation led to a pool of persistent strains 
that were responsible for similar transmission events after 
exportation to Europe via migration.
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Among 34 men with proctitis in Buenos Aires, Argentina, 
16 (47%) had Chlamydia trachomatis infection, 11 (68.8%) 
of which were biovar lymphogranuloma venereum. The 
outbreak was probably local, as in Europe. In Argentina, lym-
phogranuloma venereum should be a suspected cause of 
proctitis in HIV-infected men who have had unprotected anal 
sex with men.
Lymphogranuloma venereum (LGV) is a sexually trans-mitted infection caused by Chlamydia trachomatis 
serovars L1, L2, or L3 and their variants. LGV has been 
considered endemic to Asia, Africa, and the tropical region 
of South America. Over the past 2 decades, case reports of 
LGV in Argentina have been sporadic and regarding only 
patients who acquired the infection abroad.
In the Netherlands in 2003, an outbreak of rec-
tal LGV among men who have sex with men (MSM), 
mainly HIV infected, was reported (1). This report was 
followed by many other reports from other developed 
countries (2,3).
LGV has been traditionally described as causing 
inflammation and swelling of the inguinal lymph nodes 
and also involving the rectum, causing acute proctitis, 
particularly among HIV-infected MSM (4). Since 2015, 
some clinicians in Argentina have suspected LGV in 
certain patients with proctitis (regardless of association 
with inflammatory tumors) in which C. trachomatis has 
been detected but not genotyped. Thus, we conducted 
a prospective study to assess the C. trachomatis geno-
types as the causative agent of infectious proctitis in 
Buenos Aires, Argentina. Our study was conducted in a 
private practice and a public hospital, under a protocol 
previously approved by the hospital’s ethics committee 
(no. 201723).
From September 1, 2017, through February 1, 2018, 
we included in our study every man who visited either 
the private or public study site and who had rectal signs 
or symptoms of proctitis and had not taken antimicrobial 
drugs in the previous month. None of the included patients 
was referred by a previously included patient. Each partici-
pant signed an informed consent form. 
Over the first 5 months, we obtained a rectal swab 
sample from 34 men on their first visit. To detect C. tra-
chomatis, we extracted DNA from the samples by us-
ing real-time PCR targeting a cryptic plasmid fragment 
(Alert PCR; ELITech Molecular Diagnostics, https://
www.elitechgroup.com). Positive samples were geno-
typed by ompA-based PCR restricted fragment length 
polymorphism (5).
Of the 34 samples analyzed, 16 were positive for 
C. trachomatis; 11 were identified as genotype L2 and 5 
as genotypes D, F, or J. All participants reported having 
engaged in unprotected receptive anal sex in Argentina, 
except for 1 who had had receptive anal sex while in Mex-
ico. None declared having traveled to an LGV-endemic 
area. Mean age was 31.63 years (range 22–43 years). All 
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